Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.

The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).